Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics

Daptomycin (DAP) is increasingly used as a part of combination therapy, particularly in complex methicillin-resistant Staphylococcus aureus (MRSA) infections. While multiple studies have reported the potential for synergy between DAP and adjunctive anti-infectives, few have examined the influence of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Berti, Andrew D., Wergin, Justine E., Girdaukas, Gary G., Hetzel, Scott J., Sakoulas, George, Rose, Warren E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2012
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457407/
https://ncbi.nlm.nih.gov/pubmed/22802248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00502-12
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi